Clinical trial
A Randomized, Double-blind, Parallel-group Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus (T1DM) Compared to Placebo
NCT03688711 is registered in ClinicalTrials.gov with Zealand Pharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Parallel-group Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Rescue Treatment of Hypoglycemia in Subjects With Type 1 Diabetes Mellitus (T1DM) Compared to Placebo
- Lead sponsor
- Zealand Pharma
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 1, 2018
- Completion date
- March 11, 2019
- Enrollment
- 45 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.